Skip to main navigation Skip to search Skip to main content

The neoadjuvant model is still the future for drug development in breast cancer

  • Angela De Michele
  • , Douglas Yee
  • , Donald A. Berry
  • , Kathy S. Albain
  • , Christopher C. Benz
  • , Judy Boughey
  • , Meredith Buxton
  • , Stephen K. Chia
  • , Amy J. Chien
  • , Stephen Y. Chui
  • , Amy Clark
  • , Kirsten Edmiston
  • , Anthony D. Elias
  • , Andres Forero-Torres
  • , Tufia C. Haddad
  • , Barbara Haley
  • , Paul Haluska
  • , Nola M. Hylton
  • , Claudine Isaacs
  • , Henry Kaplan
    • Larissa Korde, Brian Leyland-Jones, Minetta C. Liu, Michelle Melisko, Susan E. Minton, Stacy L. Moulder, Rita Nanda, Olufunmilayo I. Olopade, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Emanuel F. Petricoin, Hope Rugo, Fraser Symmans, Debasish Tripathy, Laura J. Van't Veer, Rebecca K. Viscusi, Anne Wallace, Denise Wolf, Christina Yau, Laura J. Esserman

Research output: Contribution to journal › Article › peer-review

80   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The neoadjuvant model is still the future for drug development in breast cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology